These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18267277)

  • 81. [The neuroimaging features of Parkinson's disease and dystonia by transcranial sonography].
    Xiao F; Zhang Y; Sheng Y; Chen X; Luo W; Mao C; Xiong K; Liu C
    Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(15):1135-9. PubMed ID: 26081355
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease.
    Schapira AH
    Mov Disord; 2008; 23 Suppl 3():S515-20. PubMed ID: 18781678
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus.
    Cardoso EF; Maia FM; Fregni F; Myczkowski ML; Melo LM; Sato JR; Marcolin MA; Rigonatti SP; Cruz AC; Barbosa ER; Amaro E
    Neuroimage; 2009 Aug; 47(2):467-72. PubMed ID: 19398020
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Substantia nigra hyperechogenicity in Parkinson's disease.
    Bor-Seng-Shu E; Fonoff ET; Barbosa ER; Teixeira MJ
    Acta Neurochir (Wien); 2010 Dec; 152(12):2085-7. PubMed ID: 20623147
    [No Abstract]   [Full Text] [Related]  

  • 85. Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson's Disease.
    Zhang S; Tao K; Wang J; Duan Y; Wang B; Liu X
    Front Cell Neurosci; 2020; 14():216. PubMed ID: 32848616
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Transcranial sonography in movement disorders.
    Berg D; Godau J; Walter U
    Lancet Neurol; 2008 Nov; 7(11):1044-55. PubMed ID: 18940694
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract.
    Van Camp N; Blockx I; Verhoye M; Casteels C; Coun F; Leemans A; Sijbers J; Baekelandt V; Van Laere K; Van der Linden A
    NMR Biomed; 2009 Aug; 22(7):697-706. PubMed ID: 19378292
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Differentiating Parkinson's disease from other parkinsonian disorders.
    Alvarez MV; Evidente VG; Driver-Dunckley ED
    Semin Neurol; 2007 Sep; 27(4):356-62. PubMed ID: 17701873
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Is transcranial sonography useful for diagnosing Parkinson's disease in clinical practice?
    Grippe TC; Allam N; Brandão PRP; Pereira DA; Cardoso FEC; Aguilar ACR; Kessler IM
    Arq Neuropsiquiatr; 2018 Jul; 76(7):459-466. PubMed ID: 30066797
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging.
    Berg D; Supprian T; Hofmann E; Zeiler B; Jäger A; Lange KW; Reiners K; Becker T; Becker G
    J Neurol; 1999 Dec; 246(12):1186-93. PubMed ID: 10653314
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Diagnosis and the premotor phase of Parkinson disease.
    Tolosa E; Gaig C; Santamaría J; Compta Y
    Neurology; 2009 Feb; 72(7 Suppl):S12-20. PubMed ID: 19221308
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Recognition and management of Parkinson's disease during the premotor (prodromal) phase.
    Truong DD; Wolters EC
    Expert Rev Neurother; 2009 Jun; 9(6):847-57. PubMed ID: 19496688
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Early diagnosis of Parkinson's disease and initiation of treatment.
    Weiner WJ
    Rev Neurol Dis; 2008; 5(2):46-53; quiz 54-5. PubMed ID: 18660736
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.
    Kas A; Bottlaender M; Gallezot JD; Vidailhet M; Villafane G; Grégoire MC; Coulon C; Valette H; Dollé F; Ribeiro MJ; Hantraye P; Remy P
    J Cereb Blood Flow Metab; 2009 Sep; 29(9):1601-8. PubMed ID: 19491921
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Transcranial sonography and the pocket smell test in the differential diagnosis between parkinson's disease and essential tremor.
    Štenc Bradvica I; Mihaljević I; Butković-Soldo S; Kadojić D; Titlić M; Bradvica M; Kralik K
    Neurol Sci; 2015 Aug; 36(8):1403-10. PubMed ID: 25787809
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Transcranial sonography in spinocerebellar ataxia type 2.
    Mijajlović M; Dragasević N; Stefanova E; Petrović I; Svetel M; Kostić VS
    J Neurol; 2008 Aug; 255(8):1164-7. PubMed ID: 18458857
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease.
    Herzog CD; Brown L; Gammon D; Kruegel B; Lin R; Wilson A; Bolton A; Printz M; Gasmi M; Bishop KM; Kordower JH; Bartus RT
    Neurosurgery; 2009 Apr; 64(4):602-12; discussion 612-3. PubMed ID: 19349823
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Case studies in the advancement of Parkinson's disease.
    Frei K; Truong DD; Wolters E
    CNS Spectr; 2008 Dec; 13(12 Suppl 18):1-6. PubMed ID: 19179948
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.
    Berg D; Hochstrasser H; Schweitzer KJ; Riess O
    Neurotox Res; 2006 Jan; 9(1):1-13. PubMed ID: 16464747
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Transcranial brain parenchymal sonography in neurodegenerative and psychiatric diseases.
    Mijajlovic MD; Tsivgoulis G; Sternic N
    J Ultrasound Med; 2014 Dec; 33(12):2061-8. PubMed ID: 25425361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.